로딩 중…
지수 로딩 중…
DreamCIS, Inc.
223250· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,560-4.56%
2026-06-19
Price Chart
DreamCIS, Inc.-11.44%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 87.58B KRW |
| Revenue | 69.87B KRW |
| Net Income | 6.40B KRW |
| Total Assets | 162.93B KRW |
| Net Assets | 88.18B KRW |
| Employees | 358 |
| Value | |
| P/E | 13.68x |
| P/B | 0.99x |
| P/S | 1.25x |
| EV/EBITDA | 17.12x |
| FCF Yield | 13.52% |
| Profitability | |
| ROE | 7.26% |
| ROA | 3.93% |
| Op. Margin | 6.37% |
| Revenue Growth | 22.87% |
| Earnings Growth | -130.34% |
| Financial Health | |
| Debt Ratio | 184.77% |
| Total Debt | 14.84B KRW |
| FCF | 11.84B KRW |
| Cash | 26.24B KRW |
| Current Ratio | 1.07x |
| Net Debt/EBITDA | -2.56x |
| Performance | |
| 1Y Return | -11.44% |
| 1M Return | -35.04% |
| From 52W High | -58.80% |
| 1Y MDD | -53.71% |
| Trading | |
| Volume | 157,435 shares |
| Foreign Own. | 50.27% |
| Per Share | |
| EPS | 257 KRW |
| BPS | 3,206 KRW |
Company Info
Dream CIS, a Clinical Research Organization (CRO) established in 2000, saw China's top CRO, Tigermed, acquire a stake in 2015. The company provides full-range services including clinical trial design, consulting, and monitoring, as well as comprehensive specialized services such as drug clinical trials, post-market surveillance, and statistical analysis. Leveraging Tigermed's global network, Dream CIS establishes a foundation for multinational clinical trial orders and secures competitiveness through the integration of standard operating procedures. Dream CIS was established in 2000 and is headquartered in Jongno-gu, Seoul.